Cargando...
Cancer immunotherapies targeting the PD-1 signaling pathway
Immunotherapy has recently emerged as the fourth pillar of cancer treatment, joining surgery, radiation, and chemotherapy. While early immunotherapies focused on accelerating T-cell activity, current immune-checkpoint inhibitors take the brakes off the anti-tumor immune responses. Successful clinica...
Guardado en:
| Publicado en: | J Biomed Sci |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5381059/ https://ncbi.nlm.nih.gov/pubmed/28376884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-017-0329-9 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|